Table 1.
Summary of described phenotypes arising from inactivation/activation of ADAMTS genes or versican in the CCM mouse model
Abbreviated nameGenotypePhenotypeVivariumStrain
Krit1ECKO, Krit1BECKO VE-Cadherin-CreERT2; Krit1fl/fl or Slco1c1(BAC)-Cre; Krit1fl/fl Numerous lesions in the hindbrain University of Pennsylvania Mixed 
Ccm2ECKO VE-Cadherin-CreERT2; Ccm2fl/fl Same as Krit1(B)ECKO Centenary Institute Mixed 
N/A PDGFb-CreERT2; Pdcd10fl/− Same as Krit1(B)ECKO Duke University C57BL/6J 
Krit1ECKO; Adamts4−/− VE-Cadherin-CreERT2; Krit1fl/fl; Adamts4−/− No reduction in lesion formation University of Pennsylvania Mixed 
Krit1ECKO; Adamts1fl/− VE-Cadherin-CreERT2; Krit1fl/fl; Adamts1fl/− No reduction in lesion formation University of Pennsylvania Mixed 
Krit1ECKO; Adamts1fl/fl; Adamts4−/− VE-Cadherin-CreERT2; Krit1fl/fl; Adamts1fl/fl; Adamts4−/− No reduction in lesion formation University of Pennsylvania Mixed 
Ccm2ECKO; Adamts5−/− VE-Cadherin-CreERT2; Ccm2fl/fl; Adamts5−/− Significant reduction in lesion formation Centenary Institute Mixed 
Krit1ECKO; Adamts5fl/flVE-Cadherin-CreERT2; Krit1fl/fl; Adamts5fl/flSignificant reduction in lesion formation University of Pennsylvania Mixed 
ADAMTS5BEC-GOF + doxycycline Slco1c1(BAC)-Cre; LSL-rtTA; tetO-Adamts5 Nascent CCM-like vascular changes University of Pennsylvania Mixed 
Krit1BECKO + doxycycline Slco1c1(BAC)-Cre; Krit1fl/fl Significant reduction in lesion formation University of Pennsylvania Mixed 
Krit1BECKO; ADAMTS5BEC-GOF + doxycycline Slco1c1(BAC)-Cre; Krit1fl/fl; LSL-rtTA; tetO-Adamts5 Increase in lesion formation University of Pennsylvania Mixed 
Krit1ECKO; VcanRC/+ VE-Cadherin-CreERT2; Krit1fl/fl; VcanRC/+ Significant reduction in lesion formation University of Pennsylvania Mixed 
Abbreviated nameGenotypePhenotypeVivariumStrain
Krit1ECKO, Krit1BECKO VE-Cadherin-CreERT2; Krit1fl/fl or Slco1c1(BAC)-Cre; Krit1fl/fl Numerous lesions in the hindbrain University of Pennsylvania Mixed 
Ccm2ECKO VE-Cadherin-CreERT2; Ccm2fl/fl Same as Krit1(B)ECKO Centenary Institute Mixed 
N/A PDGFb-CreERT2; Pdcd10fl/− Same as Krit1(B)ECKO Duke University C57BL/6J 
Krit1ECKO; Adamts4−/− VE-Cadherin-CreERT2; Krit1fl/fl; Adamts4−/− No reduction in lesion formation University of Pennsylvania Mixed 
Krit1ECKO; Adamts1fl/− VE-Cadherin-CreERT2; Krit1fl/fl; Adamts1fl/− No reduction in lesion formation University of Pennsylvania Mixed 
Krit1ECKO; Adamts1fl/fl; Adamts4−/− VE-Cadherin-CreERT2; Krit1fl/fl; Adamts1fl/fl; Adamts4−/− No reduction in lesion formation University of Pennsylvania Mixed 
Ccm2ECKO; Adamts5−/− VE-Cadherin-CreERT2; Ccm2fl/fl; Adamts5−/− Significant reduction in lesion formation Centenary Institute Mixed 
Krit1ECKO; Adamts5fl/flVE-Cadherin-CreERT2; Krit1fl/fl; Adamts5fl/flSignificant reduction in lesion formation University of Pennsylvania Mixed 
ADAMTS5BEC-GOF + doxycycline Slco1c1(BAC)-Cre; LSL-rtTA; tetO-Adamts5 Nascent CCM-like vascular changes University of Pennsylvania Mixed 
Krit1BECKO + doxycycline Slco1c1(BAC)-Cre; Krit1fl/fl Significant reduction in lesion formation University of Pennsylvania Mixed 
Krit1BECKO; ADAMTS5BEC-GOF + doxycycline Slco1c1(BAC)-Cre; Krit1fl/fl; LSL-rtTA; tetO-Adamts5 Increase in lesion formation University of Pennsylvania Mixed 
Krit1ECKO; VcanRC/+ VE-Cadherin-CreERT2; Krit1fl/fl; VcanRC/+ Significant reduction in lesion formation University of Pennsylvania Mixed 

or Create an Account

Close Modal
Close Modal